Abstract:Therapeutic Advances in Drug Safety, Volume 15, Issue , January-December 2024. Background:Connective tissue diseases (CTD), including systemic lupus erythematosus and rheumatoid arthritis (RA), have long been treated with hydroxychloroquine (HCQ). However, prolonged HCQ use poses a risk of adverse effects, particularly retinopathy.Objective:To detect early retinal changes assessed by optical coherence tomography angiography (OCTA) in CTD patients with long-term HCQ treatment and to explore the relationship between OCTA parameters and the concentrations of HCQ and its metabolites.Design:A cross-sectional study conducted from March 2020 to October 2021 at the First Affiliated Hospital of Anhui Medical University.Methods:The area and perimeter of the foveal avascular zone (FAZ), the thickness of the fovea and parafovea, and the vascular density of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) in each area of the macula were measured by OCTA in 43 CTD patients treated with HCQ for over 6 months. Meantime, blood concentrations of HCQ and its metabolites were determined by high-performance liquid chromatography-tandem mass spectrometry, and the clinical documents of all 43 involved patients were collected.Results:There is no significant correlation between OCTA outcomes and the patient's age, disease duration, and weight-dependent dose. HCQ cumulative duration positively correlated with FAZ area and perimeter (r = 0.419, p = 0.005 and r = 0.407, p = 0.007, respectively) and negatively correlated with the foveal vessel density in DCP (r = −0.378, p = 0.012). HCQ cumulative dose had a positive correlation with FAZ area and perimeter (r = 0.445, p = 0.003 and r = 0.434, p = 0.004, respectively) and had a negative correlation with foveal vessel density in SCP and DCP (r = −0.383, p = 0.011 and r = −0.424, p = 0.005, respectively). OCTA outcomes did not correlate with HCQ and its metabolite concentrations.Conclusion:OCTA could be used to detect microvascular changes in the macula of CTD patients with long-term HCQ therapy. It was not found the concentrations of HCQ and its metabolites were associated with retinal vascular changes.Plain language summaryRetinal microvascular changes were assessed in connective tissue disease patients treated with hydroxychloroquineIntroduction:Long-term use of hydroxychloroquine (HCQ) may affect the eyes. In this study, we aimed to identify early eye changes in people with connective tissue diseases (CTD) who have been using HCQ for an extended period. Additionally, we wanted to explore the relationship between these changes and the amount of HCQ and its byproducts in their bodies.Methods:Between March 2020 and October 2021, we enrolled 43 patients with CTD who had been taking HCQ for more than 6 months. We collected various clinical information, including gender, age, diagnosis, disease duration, HCQ dosage, and treatment duration. We used specialized imaging called optical coherence tomography angiography (OCTA) to detect early microvascular changes in the macula and employed high-performance liquid chromatography-tandem mass spectrometry to measure HCQ and its metabolites in the blood. We also analyzed the relationships between these outcomes.Results:Our study did not reveal significant associations between OCTA results and patients' age, disease duration, or HCQ dosage based on their weight. However, we found that as the duration of HCQ use increased, the size (area and perimeter) of the foveal avascular zone (FAZ) in the eye grew larger. Additionally, in individuals who had used HCQ for an extended period, the density of blood vessels in the back of the eye was lower in the foveal area. Importantly, OCTA parameters did not correlate with the blood concentrations of HCQ and its metabolites.Conclusions:Our use of OCTA detected subtle changes in the blood vessels at the center of the eye in people with CTD who had been using HCQ for an extended period. Notably, these OCTA parameters did not show any connection with the blood concentrations of HCQ and its metabolites.

30‐kDa Trypsin‐like Proteases in the Plantar Stratum Corneum

Evaluation of early retinal changes in patients on long-term hydroxychloroquine using optical coherence tomography angiography

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus

Living in a Restricted Occupational World: The Occupational Experiences of Stroke Survivors who are Wheelchair Users and Their Caregivers

Retinal Microvasculature and Conjunctival Vessel Alterations in Patients With Systemic Lupus Erythematosus—An Optical Coherence Tomography Angiography Study

Microvascular Density Analysis of Patients with Inactive Systemic Lupus Erythematosus—A Two-Year Follow-Up Optical Coherence Tomography Angiography Study

Retinal alterations in evaluation of rheumatoid arthritis with chloroquine treatment: a new approach

Photoreceptor outer segment reflectivity with ultrahigh resolution visible light optical coherence tomography in systemic hydroxychloroquine use

Association between hydroxychloroquine intake and damage to the outer nuclear layer in eyes without manifest retinal toxicity

Quantitative assessment of retinal vasculature changes in systemic lupus erythematosus using wide-field OCTA and the correlation with disease activity

Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement

Microvascular alterations of the ocular surface and retina in connective tissue disease-related interstitial lung disease

Vision-Related Quality of Life in Patients with Systemic Lupus Erythematosus

Ascending monoamine-containing fiber pathways related to intracranial self-stimulation: histochemical fluorescence study.

Risk of uveitis in autoimmune diseases patients treated with hydroxychloroquine: A population‐based retrospective cohort study

Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it

Automated Evaluation of Ellipsoid Zone At-Risk Burden for Detection of Hydroxychloroquine Retinopathy

Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China.

Perforating branches of the middle cerebral artery. An anatomical study.

Automated analysis of choroidal thickness in patients with systemic lupus erithematosus treated with hydroxychloroquine

Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull's Eye Maculopathy